MarcA Ro

[JACC Journals @JACCJournals]

This multicenter study of 43 consecutive patients with severe AS reported the outcomes of #TAVR with a novel transfemoral, self-expanding #THV - the #JenaValve Trilogy https://t.co/K6YLwHsisC

#JACCINT #vhdAS

[Sean van Diepen @seanvandiepen]

DanGer Shock! The first temporary mechanical support device shown to reduce mortality in patients with cardiogenic shock but there is an increased risk of complications. @ShashankSinhaMD @ShelleyZieroth @JasonKatzMD @thiele_holger @DrDamluji @agtruesdell @Cardio_Girl

[Philip Wenzel @PhilipWenzel_76]

🔥out now —> here’s our new paper from the MyBiopsy-HF study — enjoy !👉🏻Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure | Clinical Research in Cardiology https://t.co/pIMozARJL2

[Univ.-Prof. Dr. Ralph Stephan von Bardeleben @vonBardelebenRS]

The #ApolloEU #trial is now training and initiating trial centers in #Germany in December 2023. A new perspective for patients not suitable for heart surgery and #Mitralvalve TEER procedures. Initial US safety data very promising!
More information [email protected]

[lukashobohm @lukashobohm]

Happy to discuss results about catheter-directed treatment #cdt from our presented socio-economic model with leaders in the field of #pulmonaryembolism and the current president of the #PERTconsortium #aha2023 @RosovskyRachel #timothymorris @StavrosKonstan7

[Univ.-Prof. Dr. Ralph Stephan von Bardeleben @vonBardelebenRS]

Worldwide first commercial #EVOQUE case today at #HeartvalveCenter #Mainz ⁦@UnimedizinMainz⁩ closing the loop from interventional innovation to clinical reality a result of robust science a fantastic newly enhanced heart team. ⁦@PhilippLurz⁩ ⁦@vonBardelebenRS⁩

[EHJ Editor-in-Chief @ehj_ed]

News in EHJ: Promises and challenges of targeting anti-CXCR3 autoantibodies in cardiovascular disease!

https://t.co/99mtq8h7Ld

#cardioprotective #therapy #autoantibodies #G-protein #receptors #cardiotwitter @escardio @ESC_journals

[Univ.-Prof. Dr. Ralph Stephan von Bardeleben @vonBardelebenRS]

First implant worldwide of #Topaz transcatheter Tricuspid replacement in torrential TR in comb with pacemaker lead at Heart Valve Center in #Mainz and new in class 4D ICE to be shown at #EACTS in Vienna and #TCT in #SanFrancisco ⁦@vonBardelebenRS⁩ https://t.co/TQGn8WLhyi

[Arbeitsgruppe Akuter Thoraxschmerz (AG 44) @AG44_DGK]

Donnerstag, 11h, Saal 12! AG44 goes DGK FT23!

[Philip Wenzel @PhilipWenzel_76]

How come that noise exposure worsens outcomes post MI? Here‘s our new translational paper how environmental stress promotes vascular inflammation and deterioration of cardiac function @tmuenzel @OmarHahad @dzhk_germany https://t.co/pPItiqaB3u

[lukashobohm @lukashobohm]

Our recent study demonstrated a considerable impact of COVID-19 on adverse outcomes of patients with #pulmonaryembolism in 2020, which should guide attention to this special population. https://t.co/WTfdEfBLpq

@EuroRespSoc @escardio @DIVI_eV @UnimedizinMainz